Isolated nucleic acid molecules which encode tumor rejection antigens found in dage
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 15, 2002
Issued Date -
N/A
app pub date -
Aug 11, 1998
filing date -
Sep 30, 1994
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as DAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as GAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigens, and their precursor molecules are described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully